|
UBE2D1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.674200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.803500E-02 |
| Normal-vs-Stage2 |
6.703600E-01 |
| Normal-vs-Stage3 |
7.119600E-01 |
| Normal-vs-Stage4 |
8.080600E-01 |
| Stage1-vs-Stage2 |
5.047800E-01 |
| Stage1-vs-Stage3 |
4.930600E-01 |
| Stage1-vs-Stage4 |
9.526100E-02 |
| Stage2-vs-Stage3 |
9.715800E-01 |
| Stage2-vs-Stage4 |
7.882800E-01 |
| Stage3-vs-Stage4 |
8.300400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.296800E-01 |
| Normal-vs-AfricanAmerican |
9.538500E-02 |
| Normal-vs-Asian |
7.236400E-01 |
| Caucasian-vs-AfricanAmerican |
2.792000E-01 |
| Caucasian-vs-Asian |
9.877200E-01 |
| AfricanAmerican-vs-Asian |
6.313000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.460800E-01 |
| Normal-vs-Female |
1.071630E-01 |
| Male-vs-Female |
2.908600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.177200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.968590E-01 |
| Normal-vs-Age(61-80Yrs) |
4.158000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.297400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.600000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.176800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.041600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.091400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.674200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.982800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.229200E-01 |
| Normal-vs-Grade 2 |
5.615400E-01 |
| Normal-vs-Grade 3 |
4.840500E-02 |
| Normal-vs-Grade 4 |
9.468000E-01 |
| Grade 1-vs-Grade 2 |
4.577200E-01 |
| Grade 1-vs-Grade 3 |
9.586200E-01 |
| Grade 1-vs-Grade 4 |
2.374400E-01 |
| Grade 2-vs-Grade 3 |
2.142800E-01 |
| Grade 2-vs-Grade 4 |
5.991200E-01 |
| Grade 3-vs-Grade 4 |
4.986500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.655900E-02 |
| Normal-vs-ccB subtype |
8.730200E-01 |
| ccA subtype-vs-ccB subtype |
7.657900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.267200E-01 |
| Normal-vs-N1 |
4.316000E-01 |
| N0-vs-N1 |
4.391400E-01 |
|
|
